Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleNeurology

Reshaping the Amyloid Buildup Curve in Alzheimer Disease? Partial-Volume Effect Correction of Longitudinal Amyloid PET Data

Michael Rullmann, Anke McLeod, Michel J. Grothe, Osama Sabri and Henryk Barthel; the Alzheimer’s Disease Neuroimaging Initiative
Journal of Nuclear Medicine December 2020, 61 (12) 1820-1824; DOI: https://doi.org/10.2967/jnumed.119.238477
Michael Rullmann
1Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anke McLeod
1Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michel J. Grothe
2German Center for Neurodegenerative Diseases–Rostock/Greifswald, Rostock, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Osama Sabri
1Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Henryk Barthel
1Department of Nuclear Medicine, University of Leipzig, Leipzig, Germany; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Additional Files
  • Figure1
    • Download figure
    • Open in new tab
    • Download powerpoint
  • FIGURE 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1.

    Example of amyloid PET/MR data with and without PVEC over time. Shown are baseline and 2-y follow-up MRI and gray matter (GM)–masked 18F-florbetapir PET data without and with PVEC for an Alzheimer dementia patient. Relative SUVR increase over time was higher with than without PVEC. GMD = gray matter density.

  • FIGURE 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2.

    Effect of PVEC on correlation of MMSE and amyloid PET. Shown is regression analysis of baseline–to–follow-up composite SUVRs vs. baseline–to–follow-up MMSE scores for amyloid PET data with vs. without PVEC. Slope is significantly steeper for PVE-corrected data (F1 = 7.1, P = 0.008). Only data with baseline MMSE scores < 28 were included in this analysis.

Tables

  • Figures
  • Additional Files
    • View popup
    TABLE 1

    Demographics of Study Cohort

    DemographicADMCIP
    n17199—
    PET follow-ups0.38*
     First17179
     Second020
    Age at baseline (y)76 ± 671 ± 80.03†
    Sex0.8*
     Male9115
     Female884
    MMSE at baseline22.4 ± 1.828 ± 1.85.2 × 10−27†
    Time from PET to corresponding MR scan (d)15 ± 1214 ± 120.34†
    Time between PET assessments (y)2.0 ± 0.12.1 ± 0.30.63†
    • ↵* Fisher exact test.

    • ↵† ANOVA.

    • View popup
    TABLE 2

    Influence of PVEC on SUVR Changes over Time

    RegionWithout PVECWith PVECP
    Left frontal cortex0.023 ± 0.140.067 ± 0.254.4 × 10−5
    Right frontal cortex0.022 ± 0.130.071 ± 0.231.6 × 10−6
    Left temporal cortex0.015 ± 0.110.058 ± 0.255.4 × 10−4
    Right temporal cortex0.017 ± 0.120.061 ± 0.277.5 × 10−4
    Left parietal cortex0.017 ± 0.150.070 ± 0.306.7 × 10−4
    Right parietal cortex0.021 ± 0.140.074 ± 0.321.7 × 10−3
    Left hippocampus0.007 ± 0.310.044 ± 0.500.027
    Right hippocampus−0.007 ± 0.280.013 ± 0.350.17
    Left Brodmann area 90.033 ± 0.170.085 ± 0.343.3 × 10−4
    Right Brodmann area 90.030 ± 0.150.084 ± 0.301.8 × 10−5
    Anterior cingulate0.018 ± 0.140.063 ± 0.281.2 × 10−3
    Occipital0.009 ± 0.100.047 ± 0.270.023
    Composite0.017 ± 0.110.061 ± 0.221.9 × 10−4

Additional Files

  • Figures
  • Tables
  • Supplemental Data

    Files in this Data Supplement:

    • Supplemental Data
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 61 (12)
Journal of Nuclear Medicine
Vol. 61, Issue 12
December 1, 2020
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Reshaping the Amyloid Buildup Curve in Alzheimer Disease? Partial-Volume Effect Correction of Longitudinal Amyloid PET Data
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Reshaping the Amyloid Buildup Curve in Alzheimer Disease? Partial-Volume Effect Correction of Longitudinal Amyloid PET Data
Michael Rullmann, Anke McLeod, Michel J. Grothe, Osama Sabri, Henryk Barthel
Journal of Nuclear Medicine Dec 2020, 61 (12) 1820-1824; DOI: 10.2967/jnumed.119.238477

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Reshaping the Amyloid Buildup Curve in Alzheimer Disease? Partial-Volume Effect Correction of Longitudinal Amyloid PET Data
Michael Rullmann, Anke McLeod, Michel J. Grothe, Osama Sabri, Henryk Barthel
Journal of Nuclear Medicine Dec 2020, 61 (12) 1820-1824; DOI: 10.2967/jnumed.119.238477
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • DISCLOSURE
    • Acknowledgments
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Comparing the Clinical Utility and Diagnostic Performance of CSF P-Tau181, P-Tau217, and P-Tau231 Assays
  • Google Scholar

More in this TOC Section

Neurology

  • Dopamine D1 Receptor Agonist PET Tracer Development: Assessment in Nonhuman Primates
  • Hypermetabolism on Pediatric PET Scans of Brain Glucose Metabolism: What Does It Signify?
  • TauIQ: A Canonical Image Based Algorithm to Quantify Tau PET Scans
Show more Neurology

Clinical

  • Addition of 131I-MIBG to PRRT (90Y-DOTATOC) for Personalized Treatment of Selected Patients with Neuroendocrine Tumors
  • SUVs Are Adequate Measures of Lesional 18F-DCFPyL Uptake in Patients with Low Prostate Cancer Disease Burden
  • Hypermetabolism on Pediatric PET Scans of Brain Glucose Metabolism: What Does It Signify?
Show more Clinical

Similar Articles

Keywords

  • PET
  • amyloid
  • longitudinal
  • partial-volume effect correction
SNMMI

© 2025 SNMMI

Powered by HighWire